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Abstract
Background: Excess body fat is a major risk factor for disease primarily due to its endocrine
activity. In recent years several criteria have been introduced to evaluate this factor. Nevertheless,
treatment need is currently assessed only on the basis of an individual's Body Mass Index (BMI),
calculated as body weight (in kg) divided by height in m2. The aim of our study was to determine
whether application of the BMI, compared to adiposity-based criteria, results in underestimation of
the number of subjects needing lifestyle intervention.
Methods: We compared treatment need based on BMI classification with four adiposity-based
criteria: percentage body fat (%BF), considered both alone and in relation to metabolic syndrome
risk (MS), waist circumference (WC), as an index of abdominal fat, and Body Fat Mass Index (BFMI,
calculated as fat mass in kg divided by height in m2) in 63 volunteers (23 men and 40 women, aged
20 – 65 years).
Results: According to the classification based on BMI, 6.3% of subjects were underweight, 52.4%
were normal weight, 30.2% were overweight, and 11.1% were obese. Agreement between the BMI
categories and the other classification criteria categories varied; the most notable discrepancy
emerged in the underweight and overweight categories. BMI compared to almost all of the other
adiposity-based criteria, identified a lower percentage of subjects for whom treatment would be
recommended. In particular, the proportion of subjects for whom clinicians would strongly
recommend weight loss on the basis of their BMI (11.1%) was significantly lower than those
identified according to WC (25.4%, p = 0.004), %BF (28.6%, p = 0.003), and MS (33.9%, p = 0.002).
Conclusion: The use of the BMI alone, as opposed to an assessment based on body composition,
to identify individuals needing lifestyle intervention may lead to unfortunate misclassifications.
Population-specific data on the relationships between body composition, morbidity, and mortality
are needed to improve the diagnosis and treatment of at-risk individuals.
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Background
It is generally accepted that several major diseases are
related to overweight and obesity. These include meta-
bolic syndrome and type 2 diabetes mellitus, cardiovascu-
lar diseases, some tumours, gallbladder diseases, non-
alcoholic steatohepatitis, sleep apnoea and osteoarthritis
[1-6]. The endocrine activity of adipose tissue is strongly
implicated in most of these diseases [7,8]. Therefore,
excess body fat rather than excess body weight is detri-
mental to health; hence, paradoxically, metabolically
obese, normal weight individuals, not deemed obese on
the basis of height and weight parameters, were found to
be hyperinsulinaemic, insulin-resistant, predisposed to
type 2 diabetes mellitus, hypertriglyceridaemic, or to have
premature coronary heart disease; these individuals
responded favourably to caloric restriction [9-11].
Health professionals should assess patients on the basis of
their body composition rather than their body weight
[12]. Thus, new clinical criteria have been introduced to
evaluate body adiposity, such as percentage body fat
(%BF), considered both alone [13] and in relation to met-
abolic syndrome risk [14], and waist circumference, as an
index of abdominal fat [1,15]. Recently, the Body Fat Mass
Index (BFMI, calculated as fat mass in kg divided by
height in m2) was introduced, in nutritional assessment,
as an additional element for assessing adiposity [16-18].
Nevertheless, treatment need is currently assessed on the
basis of an individual's Body Mass Index (BMI), calculated
as their body weight (in kg) divided by their height in m2
[1].
The aim of our study was to determine whether applica-
tion of the BMI, compared to adiposity-based criteria,
results in underestimation of the number of subjects
needing a lifestyle intervention.
Methods
Sample
A sample of 63 volunteers (all white, 23 men and 40
women, aged 20–65 years), was recruited. To be included
in the study they had to have a good health status, a sed-
entary lifestyle, and could not be on a low-calorie diet or
on drug therapy for acute or chronic illnesses. All the
recruited subjects attended the Human Nutrition and Eat-
ing Disorders Research Centre, University of Pavia,
between January 2004 and January 2005 to undergo a
nutritional assessment and body composition analysis;
the diagnostic radiology examinations were carried out at
the IRCCS Salvatore Maugeri Foundation, Pavia.
Study design
The subjects attended the dietology outpatient clinic early
in the morning after an overnight fast. On arrival, they
emptied their bladders. Anthropometric measurements
were taken. Body composition was assessed by means of
bioimpedance analysis (BIA) and then dual-energy X-ray
absorptiometry (DXA). Later in the morning, when the
examinations were complete, the subjects were allowed to
eat.
Anthropometric measurements
The subjects, wearing minimal clothing, were weighed to
the nearest 0.1 kg using a balance beam scale equipped
with a stadiometer. Their height, standing barefoot, was
measured to the nearest 0.5 cm. Their BMI was calculated
in the standard way: weight in kg divided by height in m2.
The subjects were then classified into four groups accord-
ing to the WHO BMI cut-offs [1] :
A) BMI: "underweight" : BMI < 18.5 kg/m2
"normal weight": BMI = 18.5 – 24.9 kg/m2
"overweight" : BMI = 25 – 29.9 kg/m2
"obese" : BMI ≥ 30 kg/m2
Waist circumference was measured to the nearest 0.1 cm
with a measuring tape placed at the midpoint between the
lower border of the ribs and the upper border of the pel-
vis. The subjects were then divided, according to gender-
specific waist circumference values, into three categories
denoting risk of metabolic complications [1] :
B) waist circumference as an index of abdominal fat:
"not increased" : < 80 cm females, < 94 cm males
"increased" : 80–87.9 cm females, 94–101.9 cm males
"substantially increased" : ≥ 88 cm females, ≥ 102 cm
males
Body composition assessment
To reduce methodological biases when classifying sub-
jects according to adiposity-based criteria, we used the
same methods reported by the appropriate reference stud-
ies: DXA to measure %BF (C) [13] ; and BIA to assess both
metabolic syndrome risk (D) [14] and BFMI (E) [16].
DXA was performed using a Norland RX-26 scanner (Nor-
land Corp., W, USA), which automatically gave a %BF
reading. BIA was performed using a Human Im Scan
device (Dietosystem, Milan, Italy); %BF was calculated
using Deurenberg's formula [19]. The subjects were then
classified according to different criteria:Nutrition Journal 2008, 7:5 http://www.nutritionj.com/content/7/1/5
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C) %BF: the subjects were classified according to %BF cut-
offs calculated by Gallagher et al. for the white subgroup
of their study population [13] (Table 1).
D) Metabolic syndrome risk: the subjects were classified
on the basis of %BF cut-offs calculated by Zhu in the white
subgroup of the American population that took part in
NHANES III [14] (Table 2).
E) Body Fat Mass Index: the subjects were classified
according to the BFMI cut-offs calculated by Kyle on the
basis of a very large sample of white men and women liv-
ing in Switzerland [16] (Table 3).
To classify the subjects for whom weight loss would be
recommended or strongly recommended (for each crite-
rion), we applied the following cut-offs (also see Tables 1,
2, 3).
Weight loss recommended:
(A) BMI ≥ 25 kg/m2, in both women and men;
(B) waist circumference ≥ 80 cm in women and ≥ 94 cm
in men;
(C) total body fat, expressed as percentage body fat: %BF
≥ 33% in women and ≥ 21% in men in the 20–39 years
age group, %BF ≥ 35% in women and ≥ 23% in men aged
40–59 years, %BF ≥ 38% in women and ≥ 25% in men
aged 60–79 years;
(D) metabolic syndrome risk: %BF ≥ 30.8% in women
and ≥ 21.2% in men;
(E) BFMI ≥ 8.2 kg/m2 in women and ≥ 5.2 kg/m2 in men
("overfat").
Weight loss strongly recommended:
(A) BMI ≥ 30 kg/m2 in women and men;
(B) waist circumference ≥ 88 cm in women and ≥ 102 cm
in men;
(C) total body fat, expressed as percentage body fat: %BF
≥ 39% in women and ≥ 26% in men in the 20–39 years
age group, %BF ≥ 41% in women and ≥ 29% in men aged
40–59 years, %BF ≥ 43% in women and ≥ 31% in men
aged 60–79 years;
(D) metabolic syndrome risk: %BF ≥ 37.2% in women
and ≥ 29.1% in men;
(E) BFMI ≥ 11.8 kg/m2 in women and ≥ 8.3 kg/m2 in men
(severely "overfat").
Statistical analysis
Sex-related differences in anthropometric measurements
and body fat indices were tested using unpaired t-tests or
χ2-tests. Statistical significance was defined as p < 0.05.
Agreement between BMI and abdominal fat, %BF, meta-
bolic syndrome risk, and BFMI was evaluated using Kend-
all's Tau-b test. McNemar's test was applied to evaluate
whether the percentage of subjects in whom weight loss
was deemed necessary on the basis of BMI was equal to
the percentages identified on the basis of the other body
composition assessments; similarly, the percentage of
Table 1: Percentage body fat cut-offs for white people, proposed 
by Gallagher et al. [13].
BMI (kg/m2) body fat (% weight)
Men Women
20–39 y
18.5 8 21
25.0 21 33
30.0 26 39
40–59 y
18.5 11 23
25.0 23 35
30.0 29 41
60–79 y
18.5 13 25
25.0 25 38
30.0 31 43
Table 2: Percentage body fat thresholds related to metabolic 
syndrome risk proposed by Zhu et al. for white people [14].
BMI (kg/m2) body fat (% weight)
Men Women
18.5 11.0 22.5
25.0 21.2 30.8
30.0 29.1 37.2
Table 3: Body Fat Mass Index (BFMI) cut-offs for healthy white 
adults, proposed by Kyle et al. [16].
BMI (kg/m2)B F M I  ( k g / m 2)
Men Women
18.5 1.8 3.9
25.0 5.2 8.2
30.0 8.3 11.8Nutrition Journal 2008, 7:5 http://www.nutritionj.com/content/7/1/5
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subjects whose BMI would prompt a strong recommenda-
tion to lose weight was compared to the percentages of
subjects in whom application of each of the other adipos-
ity classification criteria also revealed a definite need to
lose weight. All analyses were carried out with the statisti-
cal software program SPSS, version 13.0.
Statement of ethics
We certify that this research complied fully with all appli-
cable institutional and governmental regulations concern-
ing the ethical use of human volunteers and with the
terms of the Helsinki Declaration. The University of Pavia
ethics committee approved the study protocol, and all the
recruited subjects gave their written informed consent to
take part.
Results
The women enrolled in the study were slightly younger
than the men (38.5 ± 14 years vs 39.2 ± 13.3 years), but
this difference was not statistically significant (t = 0.201, p
= 0.841).
On average, the men recorded higher body weight, waist
circumference and BFMI values than the women, while
the women had a higher %BF and metabolic syndrome
risk (Table 4). Body fat percentage measured by DXA was
significantly linearly related to that measured by BIA (rPear-
son = 0.827, p < 0.0001).
According to the classification based on BMI, 6.3% of sub-
jects were underweight, 52.4% were normal weight,
30.2% were overweight, and 11.1% were obese. Abdomi-
nal adiposity was not increased in 63.5% of subjects,
increased in 11.1%, and substantially increased in 25.4%.
Total body fat, considered alone, was low in 3.2% of sub-
jects, normal in 49.2%, increased in 19.0%, and high in
28.6%. Metabolic syndrome risk related to %BF was low
in 7.1% of subjects, normal in 37.5%, increased in 21.4%,
and high in 33.9%. BFMI was low in 3.6% of subjects,
normal in 42.9%, increased in 32.1%, and high in 21.4%.
Metabolic syndrome risk was the only criterion to show
significant gender-related differences (χ2  = 9.430; p =
0.024): greater percentages of the women compared to the
men showed a high metabolic syndrome risk (37.1% vs
28.6%), and a low and normal metabolic syndrome risk
(8.6% vs 4.8% and 45.7% vs 23.8%, respectively); con-
versely, a greater proportion of the men had an increased
metabolic syndrome risk (42.9% vs 8.6%).
Agreement between the BMI categories and the other clas-
sification criteria categories varied (Table 5). The most
notable discrepancy emerged in the underweight and
overweight categories. Of the subjects classed as under-
weight on the basis of BMI, 75% had normal %BF and
metabolic syndrome risk values, and none had an
increased waist circumference. In the BMI normal weight
subjects, increased abdominal fat was found in 9.1%,
increased %BF in 15.2%, and increased metabolic syn-
drome risk in 20%; a high %BF was found in 6.1% of the
normal weight subjects and a high metabolic syndrome
risk in 16.7%. In the overweight subjects, a marked dis-
crepancy emerged between the BMI and the adiposity
indices: more than 50% of the subjects had a high %BF
and metabolic syndrome risk and just under 50% high
abdominal fat. In the subjects rated as obese on the basis
of their BMI, there was good agreement between all the
criteria.
Comparing the BMI with the BFMI categories, 75% of the
underweight subjects had a normal fat status. In the BMI
normal weight category, 30% of the subjects were "over-
fat" according to the BFMI, while in the overweight cate-
gory only 6.7% of subjects had a normal fat status and
40% had a severely "overfat" status. There was good agree-
ment between BMI and BFMI in the obese subjects. Over-
all, the BMI showed good agreement with BFMI (tau-b
Kendall = 0.722, p < 0.001) and waist circumference
(abdominal fat) (tau-b Kendall = 0.704, p < 0.001). The
level of agreement between the various BMI categories
and the %BF and metabolic syndrome risk categories was
moderate (tau-b Kendall = 0.672, p < 0.001 and tau-b
Kendall = 0.563, p < 0.001 respectively).
The percentages of subjects for whom weight loss treat-
ment would be recommended and strongly recom-
mended, on the basis of each criterion, are summarised in
figure 1. The proportion of subjects for whom clinicians
would recommend weight loss on the basis of their BMI
(41.3%) was not significantly different from the propor-
Table 4: Summary of statistics by sex (mean values and standard deviations in square brackets).
n Weight (kg) BMI (kg/m2) %BF MS WC (cm) BFMI (kg/m2)
Men 23 75.3 [11.2] 24.7 [3.9] 21.5 [8.6] 24.2 [7.6] 89.5 [10.8] 6.2 [2.8]
Women 40 62.0 [11.0] 23.8 [4.2] 34.8 [8.4] 32.6 [9.1] 80.8 [12.2] 8.0 [3.3]
Test and p-value t = 4.59
p < 0.0001
t = 0.78
p = 0.438
t = -6.00
p < 0.0001
t = -3.52
p < 0.001
t = 2.83
p = 0.006
t = -2.01
p = 0.049
%BF = total body fat, expressed as percentage body fat; MS = metabolic syndrome risk: %BF related to the risk of developing metabolic syndrome; 
WC = waist circumference, as an index of abdominal fat; BFMI = Body Fat Mass IndexNutrition Journal 2008, 7:5 http://www.nutritionj.com/content/7/1/5
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tions in whom it would be recommended on the basis of
%BF (p = 0.344) and abdominal fat (p = 0.508). Con-
versely, a significant difference emerged in relation to the
criteria metabolic syndrome risk (p = 0.022) and BFMI (p
= 0.021). The picture changes when analysing the propor-
tion of subjects for whom weight loss would be strongly
recommended, with the proportion identified on the
basis of BMI (11.1%) differing significantly from the pro-
portion identified by abdominal fat (p = 0.004), %BF (p
= 0.003), and metabolic syndrome risk (p = 0.002).
Instead, no significant difference was found between the
proportions of subjects whom clinicians, on the basis of
BMI versus BFMI, would be strongly urged to lose weight
(p = 0.125).
Discussion
Obesity is a metabolic disorder characterised by excess
body fat, which is an important risk factor for disease, not
only because it is a volume-filling organ, but primarily
due to the endocrine activity of adipose tissue [7,8,20].
Although the BMI is easily calculated and can be readily
used in population studies, it does not discriminate
between fat mass and fat-free mass, or reflect the fat mass
distribution in the body [21-25]. In our study, the BMI
compared to almost all of the other criteria, based on adi-
posity, identified a lower percentage of subjects for whom
treatment would be recommended and strongly recom-
mended. In particular, the difference was statistically sig-
nificant when the BMI was compared to metabolic
syndrome risk. These findings suggest that a certain pro-
portion of subjects classified as normal weight on the
basis of their BMI would not be recommended for treat-
ment even though they harbour excess body fat which
could have clinical and metabolic consequences. This is
also true if we compare the BMI to the BFMI, the latter an
index that denotes the amount of body fat in relation to
stature. Indeed, the BFMI, which can be considered a qual-
itative evaluation of BMI, can result in a better clinical
assessment of subjects. From a clinical point of view, bas-
ing an individual's treatment needs on their BMI can place
at risk those subjects who, on the basis of their metabolic
syndrome risk, %BF, and waist circumference, would be
strongly advised to undergo weight-loss treatment.
As regards the underweight subjects, a large proportion of
them had normal (not low) %BF, waist circumference,
metabolic syndrome risk, and BFMI values. However, in
these subjects, the misclassification does not have impor-
tant clinical consequences, since treatment would not, on
the basis of any of the criteria, be recommended for any of
them.
Thus, our data confirm that indirect estimates of body
composition (i.e. BMI) are useful for groups but unrelia-
ble in individuals [26]. Furthermore, our data also under-
line the importance of discriminating between lean mass
and fat mass, and of relating these parameters to body
Table 5: Agreement between the BMI categories and the other classification criteria categories expressed as percentage values. The 
values in bold represent the main diagonal of the agreement matrix.
Other classification criteria categories Body Mass Index
underweight normal weight overweight obese
low
%BF 25.0 3.0 - -
MS 25.0 10.0 - -
BFMI 25.0 3.3 - -
normal
%BF 75.0 75.8 15.8 -
MS 75.0 53.3 6.7 14.3
WC 100.0 90.9 31.6 -
BFMI 75.0 66.7 6.7 -
increased
%BF -1 5 . 2 31.6 14.3
MS -2 0 . 0 40.0 -
WC -9 . 1 21.1 -
BFMI -3 0 . 0 53.3 14.3
high
%BF - 6.1 52.6 85.7
MS - 16.7 53.3 85.7
WC -- 4 7 . 4 100.0
BFMI -- 4 0 . 0 85.7
%BF = total body fat, expressed as percentage body fat; MS = metabolic syndrome risk: %BF related to the risk of developing metabolic syndrome; 
WC = waist circumference, as an index of abdominal fat; BFMI = Body Fat Mass IndexNutrition Journal 2008, 7:5 http://www.nutritionj.com/content/7/1/5
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height, in order to obtain a better nutritional assessment.
In addition, the clinical consequences of an altered body
composition should be taken into account. The use of the
BMI alone to evaluate overweight and obese individuals
leads to undesirable misclassifications. Of note, our study
sample consisted of people with a sedentary lifestyle,
which may predispose them to increased adiposity even
before an increase in body weight becomes evident; this
implies that normal weight subjects can be at risk of exces-
sive adiposity.
Thus, there is a need to replace the BMI or to supplement
it with other diagnostic criteria, in particular, ones that
focus on body adiposity, considered both alone and with
regard to its distribution. If confirmed by data from larger
studies, our results highlight the need to investigate the
clinical consequences of excess body fat in normal weight
subjects. Several studies have focused on the relationship
between the BMI and morbidity and mortality [2,3,27].
Unfortunately, to date, few studies have focused on the
relationship between %BF and morbidity and mortality,
and those that have been conducted were restricted to spe-
cific ethnic groups [14,16,28-31]. Thus, precise %BF cut-
offs that can be used in clinical settings to evaluate an
individual's health remain to be determined.
Since %BF has important clinical consequences, and treat-
ment costs and drop-out rates among "overfat" subjects
are high, there is clearly a pressing need for precise and
unambiguous guidelines. In particular, %BF cut-offs
should be defined that can be used in addition to the BMI
and waist circumference values already published for the
diagnosis and treatment of at-risk subjects [1].
Conclusion
The use of the BMI alone, as opposed to an assessment
based on body composition, to identify individuals need-
ing lifestyle intervention may lead to unfortunate misclas-
sifications. Population-specific data on the relationships
between body composition, morbidity, and mortality are
needed to improve the diagnosis and treatment of at-risk
individuals.
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